SYBX synlogictx.com Earnings growth forecast for next year

Corporate emblem and logo of Synlogic Corp (SYBX)

The forward earnings per share growth forecast demonstrates stagnation as Synlogic, Inc. (SYBX) optimizes expenses and licenses technologies to preserve liquidity. Synthesis robotization and AI screening are reducing manual labor, while microbiome reprogramming creates unique "living medicines." The 0.00 metric confirms the current level, signaling a freeze in analyst expectations regarding the company's future revenues.

Synlogic Corp (SYBX): Expected net earnings per share growth next year from 07/04/2022 to 01/24/2026

SYBX (Synlogic): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Stock Price Synlogic Inc.|SYBX - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Synlogic|SYBX - Total Company Value
- book capitalization indicators:
Net Assets per Single Share Synlogic|SYBX - Total Stockholders' Equity|Market Value to Book Value Ratio synlogictx.com|SYBX - Aggregate Company Assets
- debt and solvency information:
Total Debt to Capital Synlogic, Inc.|SYBX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Synlogic Inc.|SYBX - Company Total Debt Obligations|Debt to Book Capitalization Ratio Synlogic|SYBX - Company Long-Term Liabilities|Company Short-Term Debt Synlogic|Quick Liquidity Indicator synlogictx.com
- net income and valuation ratios data:
SYBX - Company Net Income|Expected Profit Synlogic, Inc.|SYBX - Price to Earnings Multiple|Future Price to Earnings Synlogic Inc.|SYBX - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Synlogic|SYBX - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) Synlogic|SYBX - Net earnings per share for the trailing year|Quarterly EPS earnings growth synlogictx.com|SYBX - Expected net earnings per share growth this year|Earnings growth forecast for next year Synlogic, Inc.
Initial company analysis:SYBX, Synlogic, Inc.
Finished products of Synlogic Inc.

For Synlogic, Inc. (SYBX), whose synthetic biopharmaceutical patents protect R&D investments, the expected EPS growth rate for the coming year serves as an indicator of technology commercialization. This metric is calculated as the percentage ratio of projected earnings per share to the current value, reflecting the expert consensus on business growth rates. A positive trend in this indicator confirms capital stability and the absence of critical leverage during the development phase.

Analysis of competing companies

ASND (Ascendis Pharma Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year Madrigal Corp|Earnings growth forecast for next year CORT|Net earnings per share growth forecast for next year RYTM (rhythmtx.com)|Net earnings per share growth forecast for next year Akero AKRO|Metsera, Inc. (MTSR) - Expected net earnings per share growth next year|MLTX - Net earnings per share growth forecast for next year|CRNX: Net earnings per share growth forecast for next year|NAMS: Earnings growth forecast for next year|SLNO - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Amicus Therapeutics, Inc.|89bio Inc (ETNB) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Agios Pharmaceuticals Inc (AGIO)|Expected earnings per share growth for next year Structure Corp GPCR|Net earnings per share growth forecast for next year MiMedx Group, Inc. MDXG|Consensus forecast of earnings per share growth for next year rezolutebio.com (RZLT)|LXRX: Expected earnings per share growth for next year|Expected net earnings per share growth next year MBX Biosciences, Inc.|Altimmune Corp (ALT) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year AARD|Net earnings per share growth forecast for next year Sagimet Biosciences|Net earnings per share growth forecast for next year BIOA|Net earnings per share growth forecast for next year Biomea Fusion (BMEA)|QNCX - Expected net earnings per share growth next year|Earnings growth forecast for next year GUTS (Fractyl)|Net earnings per one share growth forecast for next year vTv Therapeutics, Inc.|Agape ATP Corp. - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Pluri Inc. PLUR|LPCN: Earnings growth forecast for next year|Expected earnings per share growth for next year Matinas BioPharma Holdings|Expected earnings per share growth for next year SPRB|GLTO: Expected earnings per share trend next year|Earnings growth forecast for next year CTCX|Consensus forecast of earnings per share growth for next year lumos-pharma.com|Net earnings per share growth forecast for next year Organovo ONVO|RDUS: Projected earnings per share growth rate for next year